Paper2895840
Dosage and safety of long-term suppressive acyclovir therapy for recurrent genital herpes.
Mindel A and 5 others. Lancet, 1988. Cited by 105 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Dosage and safety of long-term suppressive acyclovir therapy for recurrent genital herpes. Papers, record 2895840. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2895840
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Dosage and safety of long-term suppressive acyclovir therapy for recurrent genital herpes.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acyclovir | Major topic |
| Herpes Genitalis | Major topic |
| Immunosuppression Therapy | Major topic |
| Administration, Oral | |
| Adult | |
| Bilirubin | |
| Clinical Trials as Topic | |
| Drug Administration Schedule | |
| Female | |
| Headache | |
| Humans | |
| Male | |
| Patient Compliance | |
| Random Allocation | |
| Recurrence | |
| Tablets | |
| Time Factors |
Source PubMed
Cited by26
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 105 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41184552 | A portable poison exon for small-molecule control of mammalian gene expression. | Nat Methods | 2025 | https://conductscience.org/library/papers/41184552 | PubMed |
| 40431612 | Immunological Control of Herpes Simplex Virus Type 1 Infection: A Non-Thermal Plasma-Based Approach. | Viruses | 2025 | https://conductscience.org/library/papers/40431612 | PubMed |
| 39620271 | 2024 European guidelines for the management of genital herpes. | J Eur Acad Dermatol Venereol | 2025 | https://conductscience.org/library/papers/39620271 | PubMed |
| 39374063 | British Association of Sexual Health and HIV UK national guideline for the management of anogenital herpes, 2024. | Int J STD AIDS | 2025 | https://conductscience.org/library/papers/39374063 | PubMed |
| 33239478 | Successful treatment of elephant endotheliotropic herpesvirus infection in an Asian elephant (Elephas maximus) calf by oral acyclovir medication: Case report. | J Vet Med Sci | 2021 | https://conductscience.org/library/papers/33239478 | PubMed |
| 26983589 | Protection from lethal herpes simplex virus type 1 infection by vaccination with a UL41-deficient recombinant strain. | Fukushima J Med Sci | 2016 | https://conductscience.org/library/papers/26983589 | PubMed |
| 25086573 | Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients. | Cochrane Database Syst Rev | 2014 | https://conductscience.org/library/papers/25086573 | PubMed |
| 21865349 | Detailed analysis of mucosal herpes simplex virus-2 replication kinetics with and without antiviral therapy. | J Antimicrob Chemother | 2011 | https://conductscience.org/library/papers/21865349 | PubMed |
| 18159421 | Contemporary antiviral drug regimens for the prevention and treatment of orolabial and anogenital herpes simplex virus infection in the normal host: Four approved indications and 13 off-label uses. | Can J Infect Dis | 2003 | https://conductscience.org/library/papers/18159421 | PubMed |
| 17284082 | Clinical and therapeutic issues for herpes simplex virus-2 and HIV co-infection. | Drugs | 2007 | https://conductscience.org/library/papers/17284082 | PubMed |
| 15813644 | Psychological symptoms associated with genital herpes virus infections: epidemiology and approaches to management. | CNS Drugs | 2005 | https://conductscience.org/library/papers/15813644 | PubMed |
| 15170001 | Patient satisfaction with care for genital herpes: insights from a global survey. | Sex Transm Infect | 2004 | https://conductscience.org/library/papers/15170001 | PubMed |
| 11994034 | Genital herpes simplex virus infection in the adolescent: special considerations for management. | Paediatr Drugs | 2002 | https://conductscience.org/library/papers/11994034 | PubMed |
| 11152015 | Current recommendations for the treatment of genital herpes. | Drugs | 2000 | https://conductscience.org/library/papers/11152015 | PubMed |
| 9880471 | Genital herpes: review of the epidemic and potential use of type-specific serology. | Clin Microbiol Rev | 1999 | https://conductscience.org/library/papers/9880471 | PubMed |
| 8282300 | The effect of suppressive oral acyclovir on the psychological morbidity associated with recurrent genital herpes. | Genitourin Med | 1993 | https://conductscience.org/library/papers/8282300 | PubMed |
| 7917073 | Adverse effects of drugs used in the management of opportunistic infections associated with HIV infection. | Drug Saf | 1994 | https://conductscience.org/library/papers/7917073 | PubMed |
| 7512902 | Genital herpes. A guide to pharmacological therapy. | Drugs | 1994 | https://conductscience.org/library/papers/7512902 | PubMed |
| 2766169 | O'Brien-Bell leaves office with his concerns about two-tier system growing. Interview by Terry Moran. | CMAJ | 1989 | https://conductscience.org/library/papers/2766169 | PubMed |
| 2653790 | Acyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy. | Drugs | 1989 | https://conductscience.org/library/papers/2653790 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2895840
GET https://conductscience.org/api/papers/v1/2895840/cited_by?page=2